Physician profile
Haley Buggy
NPI 1932942257
$2,895.48
in general payments reported to CMS, 2019-2025
18 companies · $2,170 in 2025
The $2,170 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $726 · 2025: $2,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,796 · Education: $99.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,796.22 |
| Education | $99.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $588.00 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $347.04 | 2024-2025 | Ebglyss, Taltz, Zepbound |
| Incyte Corporation | $329.84 | 2024-2025 | Opzelura |
| Abbvie INC. | $277.49 | 2024-2025 | |
| Genzyme Corporation | $200.50 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $154.47 | 2024-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $150.84 | 2024-2025 | |
| Pfizer INC. | $145.42 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $130.53 | 2025 | |
| Galderma Laboratories, L.P. | $107.19 | 2025 | Nemluvio |
| Organon LLC | $97.99 | 2025 | Vtama |
| Janssen Biotech, INC. | $93.63 | 2024-2025 | Tremfya |
| Botanix Sb INC | $88.18 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $63.32 | 2025 | Zoryve |
| Leo Pharma INC. | $48.14 | 2025 | Anzupgo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi US Services INC. | $29.75 | 2025 | |
| Mayne Pharma Commercial LLC | $22.18 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.97 | 2025 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Buggy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.